The stock's fall snapped a three-day winning streak.

This was the stock's third consecutive day of gains.

Aurora Cannabis (ACB) delivered earnings and revenue surprises of -36.36% and 1.65%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Aurora Cannabis shares tumbled Wednesday as the Canadian cannabis operator said it expects “temporary declines” in its international markets, which include the U.S. ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on ...

Aurora Cannabis (ACB.TO)(ACB) has confirmed multiple AI-generated news reports published online Wednesday are false. One of the articles, published on the website Investing.com, claimed the Canadian ...

Aurora Cannabis (NASDAQ:ACB) stock falls as the company cites headwinds in its international markets while reporting better than feared Q4 FY25 revenue. Read more here.

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.